Guardant Health Inc (NASDAQ: GH) kicked off on Friday, up 4.58% from the previous trading day, before settling in for the closing price of $64.47. Over the past 52 weeks, GH has traded in a range of $20.14-$65.11.
Annual sales at Healthcare sector company slipped by -33.61% over the past five years. While this was happening, its average annual earnings per share was recorded 12.24%. With a float of $118.53 million, this company's outstanding shares have now reached $124.48 million.
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.95%, while institutional ownership is 100.34%. The most recent insider transaction that took place on Aug 21 '25, was worth 123,510. In this transaction Chief Information Officer of this company sold 2,000 shares at a rate of $61.76, taking the stock ownership to the 18,500 shares. Before that another transaction happened on Aug 21 '25, when Company's Officer proposed sale 2,000 for $61.76, making the entire transaction worth $123,510.
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.45 earnings per share (EPS), higher than consensus estimate (set at -0.6) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company's EPS will surge by 17.51% during the next five years compared to -33.61% drop over the previous five years of trading.
Take a look at Guardant Health Inc's (GH) current performance indicators. Last quarter, stock had a quick ratio of 3.35. In addition, a publicly-traded company's price to sales ratio for the trailing twelve months stands at 10.14.
For the trailing twelve months, Company's Diluted EPS (Earnings per Share) is -3.35, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -2.70 in one year's time.
Guardant Health Inc (NASDAQ: GH) saw its 5-day average volume 1.81 million, a negative change from its year-to-date volume of 2.38 million. As of the previous 9 days, the stock's Stochastic %D was 91.47%.
During the past 100 days, Guardant Health Inc's (GH) raw stochastic average was set at 99.71%, which indicates a significant increase from 99.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.04 in the past 14 days, which was lower than the 2.32 volatility it showed in the past 100 days.
At the time of writing, stock's 50-day Moving Average is $51.68, while its 200-day Moving Average is $43.74. Nevertheless, the first resistance level for the watch stands at $68.40 in the near term. At $69.37, the stock is likely to face the second major resistance level. The third major resistance level sits at $71.24. If the price goes on to break the first support level at $65.56, it is likely to go to the next support level at $63.69. The third support level lies at $62.72 if the price breaches the second support level.
The company with the Market Capitalisation of 8.41 billion has total of 124,706K Shares Outstanding. Its annual sales at the moment are 739,020 K in contrast with the sum of -436,370 K annual income. Company's last quarter sales were recorded 232,090 K and last quarter income was -99,900 K.